Mid-Link Group
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Mid-Link Group - overview
Established
2005
Location
Tianjin, -, China
Primary Industry
Biotechnology
About
Established in 2005 and based in Tianjin, China, Mid-Link Group is a medical regulations consulting and testing comprehensive service provider that focus on medical device, drug preclinical testing, animal experimentation and registration regulatory consultation. The company founder Xiaoming Hong has 17 years experience in the field of medical device quality system and registration regulations consulting. Besides she is secretary general of China Medical Device Association and professor of Shanghai University. The company established service outlets in Beijing, Tianjin, Shanghai, Jinan, Suzhou, Shenzhen, Houston and Vancouver.
The company's business covers product lifecycle services, service-based manufacturing, intelligent creation and third-party testing and certification. Mid-Link Group also provides biocompatibility testing, microbial testing, process validation and preclinical testing for customer.
Current Investors
Watson Capital, Yushan Partners, Legend Capital
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Medical Devices & Equipment, Medical Software
Website
www.mid-link.net
Verticals
Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.